Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
Go back to Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes| Abbott Laboratories (NYSE: ABT) | Delayed: 88.28 -0.13 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.41 | 52 Week High | $46.38 | |||
| Open | $88.15 | 52 Week Low | $36.00 | |||
| Day High | $88.47 | P/E | 58.85 | |||
| Day Low | $87.21 | EPS | $1.50 | |||
| Volume | 3,169,456 | |||||
